140 related articles for article (PubMed ID: 8938242)
21. Fabrication and characterization of permeable degradable poly(DL-lactide-co-glycolide) (PLGA) hollow fiber phase inversion membranes for use as nerve tract guidance channels.
Wen X; Tresco PA
Biomaterials; 2006 Jul; 27(20):3800-9. PubMed ID: 16564567
[TBL] [Abstract][Full Text] [Related]
22. Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition.
Park TG
Biomaterials; 1995 Oct; 16(15):1123-30. PubMed ID: 8562787
[TBL] [Abstract][Full Text] [Related]
23. Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.
Kranz H; Ubrich N; Maincent P; Bodmeier R
J Pharm Sci; 2000 Dec; 89(12):1558-66. PubMed ID: 11042603
[TBL] [Abstract][Full Text] [Related]
24. Effect of poly DL-lactide--co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit.
Meikle MC; Papaioannou S; Ratledge TJ; Speight PM; Watt-Smith SR; Hill PA; Reynolds JJ
Biomaterials; 1994 Jun; 15(7):513-21. PubMed ID: 7918904
[TBL] [Abstract][Full Text] [Related]
25. Non-invasive in vivo characterization of microclimate pH inside in situ forming PLGA implants using multispectral fluorescence imaging.
Schädlich A; Kempe S; Mäder K
J Control Release; 2014 Apr; 179():52-62. PubMed ID: 24503251
[TBL] [Abstract][Full Text] [Related]
26. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
[TBL] [Abstract][Full Text] [Related]
27. In vivo-in vitro study of biodegradable methadone delivery systems.
Negrin CM; Delgado A; Llabrés M; Evora C
Biomaterials; 2001 Mar; 22(6):563-70. PubMed ID: 11219720
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro.
Tracy MA; Ward KL; Firouzabadian L; Wang Y; Dong N; Qian R; Zhang Y
Biomaterials; 1999 Jun; 20(11):1057-62. PubMed ID: 10378806
[TBL] [Abstract][Full Text] [Related]
29. Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits.
Hashizoe M; Ogura Y; Takanashi T; Kunou N; Honda Y; Ikada Y
Curr Eye Res; 1997 Jul; 16(7):633-9. PubMed ID: 9222079
[TBL] [Abstract][Full Text] [Related]
30. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS
J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238
[TBL] [Abstract][Full Text] [Related]
31. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers.
Boisdron-Celle M; Menei P; Benoit JP
J Pharm Pharmacol; 1995 Feb; 47(2):108-14. PubMed ID: 7602463
[TBL] [Abstract][Full Text] [Related]
32. New technique to extend the useful life of a biodegradable cartilage implant.
Spain TL; Agrawal CM; Athanasiou KA
Tissue Eng; 1998; 4(4):343-52. PubMed ID: 9916167
[TBL] [Abstract][Full Text] [Related]
33. Formulation and characterization of injectable poly(DL-lactide-co-glycolide) implants loaded with N-acetylcysteine, a MMP inhibitor.
Desai KG; Mallery SR; Schwendeman SP
Pharm Res; 2008 Mar; 25(3):586-97. PubMed ID: 17891553
[TBL] [Abstract][Full Text] [Related]
34. Monitoring release of ketoprofen enantiomers from biodegradable poly(D,L-lactide-co-glycolide) injectable implants.
Wang SH; Liang ZH; Zeng S
Int J Pharm; 2007 Jun; 337(1-2):102-8. PubMed ID: 17296274
[TBL] [Abstract][Full Text] [Related]
35. Release behavior of poly(lactic acid-co-glycolic acid) implants containing phosphorothioate oligodeoxynucleotide.
Yamakawa I; Ishida M; Kato T; Ando H; Asakawa N
Biol Pharm Bull; 1997 Apr; 20(4):455-9. PubMed ID: 9145231
[TBL] [Abstract][Full Text] [Related]
36. Degradation and release properties of pellets fabricated from three commercial poly(D,L-lactide-co-glycolide) biodegradable polymers.
Schmitt EA; Flanagan DR; Linhardt RJ
J Pharm Sci; 1993 Mar; 82(3):326-9. PubMed ID: 8450430
[TBL] [Abstract][Full Text] [Related]
37. Novel polyphosphazene/poly(lactide-co-glycolide) blends: miscibility and degradation studies.
Ibim SE; Ambrosio AM; Kwon MS; El-Amin SF; Allcock HR; Laurencin CT
Biomaterials; 1997 Dec; 18(23):1565-9. PubMed ID: 9430340
[TBL] [Abstract][Full Text] [Related]
38. Technique to control pH in vicinity of biodegrading PLA-PGA implants.
Agrawal CM; Athanasiou KA
J Biomed Mater Res; 1997; 38(2):105-14. PubMed ID: 9178737
[TBL] [Abstract][Full Text] [Related]
39. Bone-derived growth factor release from poly(alpha-hydroxy acid) implants in vitro.
Meikle MC; Mak WY; Papaioannou S; Davies EH; Mordan N; Reynolds JJ
Biomaterials; 1993 Feb; 14(3):177-83. PubMed ID: 8386553
[TBL] [Abstract][Full Text] [Related]
40. In vivo evaluation of a novel electrically conductive polypyrrole/poly(D,L-lactide) composite and polypyrrole-coated poly(D,L-lactide-co-glycolide) membranes.
Wang Z; Roberge C; Dao LH; Wan Y; Shi G; Rouabhia M; Guidoin R; Zhang Z
J Biomed Mater Res A; 2004 Jul; 70(1):28-38. PubMed ID: 15174106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
